A randomized, double-blind, placebo-controlled, dose-ranging trial of tafenoquine for weekly prophylaxis against Plasmodium falciparum.
Tafenoquine is a promising new 8-aminoquinoline drug that may be useful for malaria prophylaxis in nonpregnant persons with normal glucose-6-phosphate dehydrogenase (G6PD) function. A randomized, double-blind, placebo-controlled chemoprophylaxis trial was conducted with adult residents of northern G...
Main Authors: | Hale, B, Owusu-Agyei, S, Fryauff, D, Koram, K, Adjuik, M, Oduro, A, Prescott, W, Baird, J, Nkrumah, F, Ritchie, T, Franke, E, Binka, F, Horton, J, Hoffman, S |
---|---|
Format: | Journal article |
Sprog: | English |
Udgivet: |
2003
|
Lignende værker
-
Incidence of symptomatic and asymptomatic Plasmodium falciparum infection following curative therapy in adult residents of northern Ghana.
af: Owusu-Agyei, S, et al.
Udgivet: (2001) -
Mefloquine treatment for uncomplicated falciparum malaria in young children 6-24 months of age in northern Ghana.
af: Fryauff, D, et al.
Udgivet: (2007) -
Seasonal malaria attack rates in infants and young children in northern Ghana.
af: Baird, J, et al.
Udgivet: (2002) -
Randomised placebo-controlled trial of primaquine for prophylaxis of falciparum and vivax malaria.
af: Fryauff, D, et al.
Udgivet: (1995) -
The antimalarial activity of tafenoquine in falciparum malaria
af: White, NJ
Udgivet: (2023)